Cargando…

Analysis of Risk Factors and Nursing Strategies for Postoperative Hemorrhage of Benign Prostatic Hyperplasia

This study is to investigate the risk factors analysis and nursing strategies for postoperative bleeding of benign prostatic hyperplasia (BPH). Totally, 240 BPH patients after surgical excision admitted to Hengshui People's Hospital between January 2019 and January 2020 were recruited. Of the 2...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jin, Shanshan, Liu, Zhaoyue, Liu, Yan, Wu, Jingzhang, Yu, Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135509/ https://www.ncbi.nlm.nih.gov/pubmed/35646136 http://dx.doi.org/10.1155/2022/4205015

Ejemplares similares

Retracted: Analysis of Risk Factors and Nursing Strategies for Postoperative Hemorrhage of Benign Prostatic Hyperplasia
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Nursing Research on Benign Prostatic Hyperplasia Based on Continuous Nursing Care
por: Li, Shasha, et al.
Publicado: (2022)

Risk factors for bladder calculi in patients with benign prostatic hyperplasia
por: Huang, Wei, et al.
Publicado: (2017)

Benign Prostatic Hyperplasia
Publicado: (2015)

Efficacy and Safety of Prostatic Artery Embolization in the Treatment of High Risk Benign Prostatic Hyperplasia and its Influence on Postoperative Life Quality of Patients
por: Wang, Kun, et al.
Publicado: (2022)

Relationship between Intravesical Prostatic Protrusion and Postoperative Outcomes in Patients with Benign Prostatic Hyperplasia
por: Lee, Jong Woo, et al.
Publicado: (2012)

Expression and Significance of D-Dimer and Fibrinogen in Hyperfibrinolysis of Elderly Patients with Bleeding after BPH Operation
por: Liu, Zhaoyue, et al.
Publicado: (2022)

Retracted: Nursing Research on Benign Prostatic Hyperplasia Based on Continuous Nursing Care
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Benign prostatic hyperplasia and subsequent risk of bladder cancer
por: Kang, D, et al.
Publicado: (2007)

Combination of transurethral resection of the prostate and flexible and rigid ureteroscopy for benign prostatic hyperplasia and ureteral calculus
por: He, Kunlun, et al.
Publicado: (2021)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Management of benign prostatic hyperplasia with silodosin
por: Yamanishi, Tomonori, et al.
Publicado: (2009)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

Botulinum toxin and benign prostatic hyperplasia
por: Ng, Lay Guat
Publicado: (2018)

Solving the benign prostatic hyperplasia puzzle
por: Foo, Keong Tatt
Publicado: (2016)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Acute urinary retention in benign prostatic hyperplasia: Risk factors and current management
por: Muruganandham, K., et al.
Publicado: (2007)

Association between Diabetes Mellitus and Hypertension in Benign Prostatic Hyperplasia Patients
por: Zeng, Xian-Tao, et al.
Publicado: (2018)

Postoperative Infectious Complications in Our Early Experience With Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
por: Shigemura, Katsumi, et al.
Publicado: (2013)

The Emerging Role of Cell Adhesion Molecules on Benign Prostatic Hyperplasia
por: Liu, Jiang, et al.
Publicado: (2023)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Linking Pre-Diabetes with Benign Prostate Hyperplasia. IGFBP-3: A Conductor of Benign Prostate Hyperplasia Development Orchestra?
por: Protopsaltis, Ioannis, et al.
Publicado: (2013)

AB104. Hemiresection of the prostate in highly risk patients with benign prostate hyperplasia
por: Shang, Panfeng, et al.
Publicado: (2014)

Relationship of Postoperative Recatheterization and Intraoperative Bladder Distention Volume in Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
por: Kim, Hyeon Jun, et al.
Publicado: (2013)

Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors
por: Parsons, J. Kellogg
Publicado: (2010)

Morphological Changes of Benign Prostatic Hyperplasia in Culture
por: McMahon, M. J., et al.
Publicado: (1973)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

VASTI THERAPY IN THE MANAGEMENT OF BENIGN PROSTATE HYPERPLASIA
por: Gupta, Shivaji, et al.
Publicado: (1997)

Current Laser Treatments for Benign Prostatic Hyperplasia
por: Son, Hwancheol, et al.
Publicado: (2010)

Benign prostatic hyperplasia: An overview of existing treatment
por: Dhingra, Neelima, et al.
Publicado: (2011)

Therapeutic options in the treatment of benign prostatic hyperplasia
por: Sandhu, Jaspreet S
Publicado: (2009)

Unsolved Issues in Managing Benign Prostatic Hyperplasia
por: Oh, Seung-June
Publicado: (2013)

Recent advances in treatment for Benign Prostatic Hyperplasia
por: van Rij, Simon, et al.
Publicado: (2015)

Diagnosis and treatment of benign prostate hyperplasia in Asia
por: Foo, Keong Tatt
Publicado: (2015)

Chromosomal aberrations in benign prostatic hyperplasia patients
por: Altok, Muammer, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_kl8hu39ni6p1mkc58881mphj09